Evidence map›Paper›PMID 24571656›Full record

ArticleBiometrics2014

Bayesian hidden Markov models to identify RNA-protein interaction sites in PAR-CLIP.

Jonghyun Yun, Tao Wang, Guanghua Xiao

Abstract read
In one paragraph

Article in Biometrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Bioinformatic tools for analysis of CLIP ribonucleoprotein data.Wiley interdisciplinary reviews. RNA · 2017
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonghyun YunDivision of Biostatistics, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, 75290, USA.
Tao Wang
Guanghua Xiao

Funding

Integrative Analysis to Identify Therapeutic Targets for Lung CancerR01CA172211 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2013 to 2017
$1.6M
Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
Secondary Data Analyses for Substance Abuse ResearchR33DA027592 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2011 to 2012
$622k
NCI NIH HHS 1R01CA172211NCI NIH HHS 5R01CA152301NCI NIH HHS R01 CA152301NCI NIH HHS R01 CA172211NIDA NIH HHS 4R33DA027592NIDA NIH HHS R33 DA027592
6 · The paper itself

Abstract

The photoactivatable ribonucleoside enhanced cross-linking immunoprecipitation (PAR-CLIP) has been increasingly used for the global mapping of RNA-protein interaction sites. There are two key features of the PAR-CLIP experiments: The sequence read tags are likely to form an enriched peak around each RNA-protein interaction site; and the cross-linking procedure is likely to introduce a specific mutation in each sequence read tag at the interaction site. Several ad hoc methods have been developed to identify the RNA-protein interaction sites using either sequence read counts or mutation counts alone; however, rigorous statistical methods for analyzing PAR-CLIP are still lacking. In this article, we propose an integrative model to establish a joint distribution of observed read and mutation counts. To pinpoint the interaction sites at single base-pair resolution, we developed a novel modeling approach that adopts non-homogeneous hidden Markov models to incorporate the nucleotide sequence at each genomic location. Both simulation studies and data application showed that our method outperforms the ad hoc methods, and provides reliable inferences for the RNA-protein binding sites from PAR-CLIP data.

Indexed as

Models, StatisticalBayes TheoremBinding SitesBiometryComputer SimulationCross-Linking ReagentsFragile X Messenger Ribonucleoprotein 1High-Throughput Nucleotide SequencingHumansImmunoprecipitationMarkov ChainsNucleic Acid ConformationProteinsProtein Structure, SecondaryRNARNA-Binding Protein FUSCross-Linking ReagentsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1ProteinsRNARNA-Binding Protein FUSBeta geometricMarkov chain Monte CarloNext generation sequencing dataNon-homogeneous hidden Markov modelPAR-CLIPRNA binding protein

Identifiers

PMID24571656
PMCPMC4061157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.